Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adherence to dietary regimens is defined by the World Health Organization as the extent to which an individual's behavior—specifically their nutritional intake—corresponds with agreed recommendations from a healthcare provider (WHO, 2003). Unlike conventional therapeutic targets such as enzymes or G protein-coupled receptors, dietary adherence is a behavioral construct and a critical clinical endpoint in the management of chronic diseases (NIH, 2021). It is not a molecule that can be targeted by small molecules or biologics in a traditional sense; however, it is a primary determinant of the success of pharmacological interventions for metabolic and cardiovascular conditions. Poor adherence is a major barrier to achieving therapeutic goals and can lead to significant increases in morbidity and healthcare costs (Cochrane Database, 2013). In biotechnology and drug development, monitoring and improving adherence is essential for the accurate assessment of drug efficacy during clinical trials and for the optimization of real-world patient outcomes.
Not applicable; this is a behavioral measure and clinical endpoint, not a molecular target for pharmacological binding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adherence to dietary regimens.